Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Estey

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
Leukemia|June 1, 1995
Change in karyotype between diagnosis and first relapse in acute myelogenous leukemiaE Estey, M J Keating, S Pierce, et al.
Leukemia & Lymphoma|January 1, 1993
Biochemical modulation of arabinosylcytosine for therapy of leukemiasV Gandhi, E Estey, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemiaV Heinemann, E Estey, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapyV Gandhi, E Estey, M J Keating, et al.
Lancet (London, England)|September 4, 1976
Lergotrile in Parkinson's diseaseA N Lieberman, M Kupersmith, E Estey, et al.
The American Journal of Medicine|February 1, 1994
What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?H Kantarjian, M Talpaz, E Estey, et al.
Leukemia|August 30, 2002
Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)G Garcia-Manero, H M Kantarjian, S Kornblau, et al.
Leukemia Research|January 1, 1995
Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemiaM Wetzler, R Kurzrock, Z Estrov, et al.
Seminars in Oncology|June 1, 1987
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-CW Plunkett, J O Liliemark, E Estey, et al.
Oncogene|August 1, 1992
Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cellsW Zhang, G Hu, E Estey, et al.
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Leukemia|June 1, 1995
Change in karyotype between diagnosis and first relapse in acute myelogenous leukemiaE Estey, M J Keating, S Pierce, et al.
Leukemia & Lymphoma|January 1, 1993
Biochemical modulation of arabinosylcytosine for therapy of leukemiasV Gandhi, E Estey, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemiaV Heinemann, E Estey, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapyV Gandhi, E Estey, M J Keating, et al.
Lancet (London, England)|September 4, 1976
Lergotrile in Parkinson's diseaseA N Lieberman, M Kupersmith, E Estey, et al.
The American Journal of Medicine|February 1, 1994
What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?H Kantarjian, M Talpaz, E Estey, et al.
Leukemia|August 30, 2002
Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)G Garcia-Manero, H M Kantarjian, S Kornblau, et al.
Leukemia Research|January 1, 1995
Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemiaM Wetzler, R Kurzrock, Z Estrov, et al.
Seminars in Oncology|June 1, 1987
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-CW Plunkett, J O Liliemark, E Estey, et al.
Oncogene|August 1, 1992
Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cellsW Zhang, G Hu, E Estey, et al.
Pageof 21